292 related articles for article (PubMed ID: 37471629)
1. Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer.
Cárdenas EL; O'Rourke RL; Menon A; Meagher J; Stuckey J; Garner AL
J Med Chem; 2023 Aug; 66(15):10734-10745. PubMed ID: 37471629
[TBL] [Abstract][Full Text] [Related]
2. Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer.
Cárdenas EL; O'Rourke RL; Menon A; Meagher J; Stuckey J; Garner AL
bioRxiv; 2023 May; ():. PubMed ID: 37292917
[TBL] [Abstract][Full Text] [Related]
3. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
[TBL] [Abstract][Full Text] [Related]
5. Discovery and characterization of conserved binding of eIF4E 1 (CBE1), a eukaryotic translation initiation factor 4E-binding plant protein.
Patrick RM; Lee JCH; Teetsel JRJ; Yang SH; Choy GS; Browning KS
J Biol Chem; 2018 Nov; 293(44):17240-17247. PubMed ID: 30213859
[TBL] [Abstract][Full Text] [Related]
6. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
Connor JH; Lyles DS
J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
[TBL] [Abstract][Full Text] [Related]
7. The nematode eukaryotic translation initiation factor 4E/G complex works with a trans-spliced leader stem-loop to enable efficient translation of trimethylguanosine-capped RNAs.
Wallace A; Filbin ME; Veo B; McFarland C; Stepinski J; Jankowska-Anyszka M; Darzynkiewicz E; Davis RE
Mol Cell Biol; 2010 Apr; 30(8):1958-70. PubMed ID: 20154140
[TBL] [Abstract][Full Text] [Related]
8. Cap-binding protein 1-mediated and eukaryotic translation initiation factor 4E-mediated pioneer rounds of translation in yeast.
Gao Q; Das B; Sherman F; Maquat LE
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4258-63. PubMed ID: 15753296
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation of eIF4E activates mRNA translation.
Xu X; Vatsyayan J; Gao C; Bakkenist CJ; Hu J
EMBO Rep; 2010 Apr; 11(4):299-304. PubMed ID: 20224576
[TBL] [Abstract][Full Text] [Related]
10. Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment.
Piserà A; Campo A; Campo S
J Genet Genomics; 2018 Jan; 45(1):13-24. PubMed ID: 29396141
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic initiation factor 4E (eIF4E): A recap of the cap-binding protein.
Batool A; Aashaq S; Andrabi KI
J Cell Biochem; 2019 Sep; 120(9):14201-14212. PubMed ID: 31074051
[TBL] [Abstract][Full Text] [Related]
12. eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation.
Lee AS; Kranzusch PJ; Doudna JA; Cate JH
Nature; 2016 Aug; 536(7614):96-9. PubMed ID: 27462815
[TBL] [Abstract][Full Text] [Related]
13. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
Ptushkina M; von der Haar T; Karim MM; Hughes JM; McCarthy JE
EMBO J; 1999 Jul; 18(14):4068-75. PubMed ID: 10406811
[TBL] [Abstract][Full Text] [Related]
14. The 4E-BP Caf20p Mediates Both eIF4E-Dependent and Independent Repression of Translation.
Castelli LM; Talavera D; Kershaw CJ; Mohammad-Qureshi SS; Costello JL; Rowe W; Sims PF; Grant CM; Hubbard SJ; Ashe MP; Pavitt GD
PLoS Genet; 2015 May; 11(5):e1005233. PubMed ID: 25973932
[TBL] [Abstract][Full Text] [Related]
15. A widespread alternate form of cap-dependent mRNA translation initiation.
de la Parra C; Ernlund A; Alard A; Ruggles K; Ueberheide B; Schneider RJ
Nat Commun; 2018 Aug; 9(1):3068. PubMed ID: 30076308
[TBL] [Abstract][Full Text] [Related]
16. Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target.
Jia Y; Polunovsky V; Bitterman PB; Wagner CR
Med Res Rev; 2012 Jul; 32(4):786-814. PubMed ID: 22495651
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotic translation initiation is controlled by cooperativity effects within ternary complexes of 4E-BP1, eIF4E, and the mRNA 5' cap.
Modrak-Wojcik A; Gorka M; Niedzwiecka K; Zdanowski K; Zuberek J; Niedzwiecka A; Stolarski R
FEBS Lett; 2013 Dec; 587(24):3928-34. PubMed ID: 24211447
[TBL] [Abstract][Full Text] [Related]
18. Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif.
Tee AR; Proud CG
Mol Cell Biol; 2002 Mar; 22(6):1674-83. PubMed ID: 11865047
[TBL] [Abstract][Full Text] [Related]
19. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.
Niedzwiecka A; Marcotrigiano J; Stepinski J; Jankowska-Anyszka M; Wyslouch-Cieszynska A; Dadlez M; Gingras AC; Mak P; Darzynkiewicz E; Sonenberg N; Burley SK; Stolarski R
J Mol Biol; 2002 Jun; 319(3):615-35. PubMed ID: 12054859
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
